Health In Tech Announces Fourth Quarter and Full Year 2025 Financial Results
STUART, Fla., March 25, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or "Company"), an AI-enabled InsurTech platform company, today announced its financial results for the fourth quarter and full year ended December 31, 2025.
Financial Highlights for the Full Year 2025 and Fourth Quarter of 2025:
Revenue Outlook
Health In Tech expects full-year 2026 revenue to be in the range of $45 million to $50 million, representing year-over-year growth of approximately 35% to 50%. This outlook is based on management's current expectations and assumptions, including continued strong demand for the Company's AI-enabled underwriting marketplace across the self-funded health insurance segment and successful deployment of new features. Actual results may differ materially due to risks and uncertainties described in Health In Tech's filings with the SEC.
The Company expects continued growth driven by expanding engagement across its distribution network and the full deployment of new features launched in January 2026. Unlike the traditional insurance industry, where new product and service implementations typically require one to two years, Health In Tech's AI-driven platform enables new capabilities to be developed and deployed within approximately one to two quarters. This accelerated development cycle provides a meaningful competitive advantage, allowing the Company to respond quickly to broker and client demand, continuously enhance its marketplace offerings, and scale its technology platform more efficiently than traditional market participants.
CEO Commentary
Tim Johnson, Chief Executive Officer of Health In Tech, commented, "2025 was a defining year of disciplined execution and measurable platform scale for Health In Tech. We strengthened our AI-enabled underwriting marketplace, expanded carrier, broker, and TPA integrations, and further automated core insurance workflows to drive efficiency and margin scalability. We extended underwriting capabilities into larger employer segments and continued enhancing our technology architecture to support enterprise-level throughput across the approximately $300 billion U.S. claims administration market. Most importantly, we translated operational progress into financial performance, delivering 71% year-over-year revenue growth."
Mr. Johnson continued, "As we enter 2026, our focus is on advancing a fully integrated marketplace model that expands beyond underwriting to include additional services such as claims administration and administrative cost-containment solutions. Building on years of assembling specialized healthcare vendors and service providers essential to self-funded plans, we enhanced our platform in January 2026 to offer more than 100 pre-configured, customized stop-loss programs tailored at the broker-agency level. This structured program architecture enables agencies to align standardized offerings with target employer segments, empowering brokers to deliver execution-ready solutions with greater speed, consistency, and operational efficiency. The result is shorter sales cycles, improved conversion visibility, and scalable distribution leverage, while maintaining the flexibility to customize for employer-specific needs.
"In the first half of 2026, we expect to complete market testing of our Three-Year Rate stabilization program, designed to provide cost stability and predictability for eligible employer groups. We also plan to initiate beta testing of a new data-driven solution that integrates physiological data and claims data to generate actionable value insights. Together, these initiatives reflect our strategy of layering incremental, high-value services onto an already commercialized and scalable platform to drive durable growth and increasing operating leverage."
Key Developments in Q1 2026
Conference Call Details
Health In Tech will host a conference call to discuss the financial results for the fourth quarter and full year of 2025 on March 25, 2026, at 5:00 p.m. (ET). To participate in our live conference call and webcast, please dial 1-888-346-8982 or 1-412-902-4272 (for international participants).
A live audio webcast will be available via the Investor Relations page of Health In Tech's website at https://healthintech.com/. A replay of the webcast will be available for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.
Non-GAAP Financial Information
This release presents Adjusted EBITDA, a non-GAAP financial metric, which is provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP"). Management uses Adjusted EBITDA to provide investors with additional insight into operational performance and to facilitate comparison with other companies in the industry. Adjusted EBITDA should not be considered an alternative to net income, operating income, or other GAAP measures. A reconciliation of historical non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.
Use of Forward‑Looking Statements
Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity.
About Health In Tech
Health In Tech, Inc. (Nasdaq: "HIT") is an AI-enabled InsurTech platform company, which offers a marketplace that improves processes in the health insurance industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs) and third-party administrators ("TPAs"). Health In Tech's platform serves as a marketplace for brokers, TPAs, MGUs and carriers to access self-funded health insurance for employers, providing functions including customized self-funded health plans, bindable stop-loss quotes, AI-enabled underwriting, claims administration and reporting integration. Learn more at healthintech.com.
Health In Tech, Inc.
Consolidated Statements of Operations
Three Months Ended
December 31,
Fiscal Year Ended
December 31,
2025
2024
2025
2024
Revenues
Revenues from underwriting modeling
(ICE)
$1,032,381
$1,697,080
$6,864,545
$6,649,271
Revenues from fees
6,476,204
3,207,484
26,462,966
12,841,635
SMR
6,476,204
2,470,284
26,462,966
9,849,300
HI Card
-
737,200
-
2,992,335
Total revenues
7,508,585
4,904,564
33,327,511
19,490,906
Cost of revenues
3,379,942
1,107,173
12,389,783
4,051,439
Gross profit
4,128,643
3,797,391
20,937,728
15,439,467
Operating expenses
Sales and marketing expenses
906,206
632,060
4,185,766
3,158,257
General and administrative expenses
3,180,137
2,848,014
13,654,262
8,477,407
Research and development expenses
213,113
633,653
1,569,262
2,813,899
Total operating expenses
4,299,456
4,113,727
19,409,290
14,449,563
Other income (expense):
Interest income
104,659
28,774
409,922
122,885
Interest expenses
-
-
-
(495,000)
Other income
-
114,055
118,399
271,211
Other expense
(377,587)
62,759
(382,587)
-
Total other income (expense), net
(272,928)
205,588
145,734
(100,904)
Income (loss) before income tax
expense
$(443,741)
$(110,748)
$1,674,172
$889,000
Provision for income taxes
141,184
(33,404)
(395,330)
(218,523)
Net income (loss)
$(302,557)
$(144,152)
$1,278,842
$670,477
Net income per share
Basic
$(0.01)
$(0.00)
$0.02
$0.01
Diluted
$(0.01)
$(0.00)
$0.02
$0.01
Weighted average common stocks
outstanding
Basic
56,908,999
52,047,723
55,843,821
51,839,329
Diluted
58,635,562
54,662,931
57,742,798
53,662,677
Health In Tech, Inc.
Consolidated Balance Sheets
December 31, 2025
December 31, 2024
Assets
Current assets
Cash and cash equivalents
$7,669,754
$7,849,248
Accounts receivable, net
756,288
1,647,103
Loans receivable, net
815,995
-
Other receivables, net
3,467,814
500,252
Deferred offering costs
170,977
-
Prepaid expenses and other current assets
3,280,148
787,161
Total current assets
16,160,976
10,783,764
Non-current assets
Software
6,530,894
3,962,461
Loans receivable, net
-
815,995
Operating lease - right of use assets
139,940
206,269
Long-term prepaid expenses
258,151
-
Total non-current assets
6,928,985
4,984,725
Total assets
$23,089,961
$15,768,489
Liabilities and stockholders' equity
Current liabilities
Accounts payable and accrued expenses
$4,188,811
$1,858,840
Income taxes payable
-
205,253
Operating lease liabilities - current
76,195
66,881
Other current liability
891,598
-
Total current liabilities
5,156,604
2,130,974
Non-current liabilities
Deferred tax liabilities
757,675
328,676
Operating lease liabilities - non-current
63,617
139,811
Total non-current liabilities
821,292
468,487
Total liabilities
5,977,896
2,599,461
Stockholders' equity
Common stock, $0.001 par value; Class A Common
stock 150,000,000 shares authorized 46,006,000 and
42,914,870 shares issued and outstanding as of
December 31, 2025 and December 31, 2024,
respectively
46,006
42,915
Common stock, $0.001 par value; Class B Common
stock 50,000,000 shares authorized, 11,700,000
shares issued and outstanding as of December 31,
2025 and December 31, 2024, respectively
11,700
11,700
Additional paid-in capital
11,834,121
9,173,017
Retained earnings
5,220,238
3,941,396
Total stockholders' equity
17,112,065
13,169,028
Total liabilities and stockholders' equity
$23,089,961
$15,768,489
Health In Tech, Inc.
Consolidated Statements of Cash Flows
Fiscal Year Ended December 31,
2025
2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income
$1,278,842
$670,477
Adjustments to reconcile net income to net cash provided by
(used in) operating activities:
Bad debt expense (recovery)
(16,234)
1,878
Amortization expense
900,577
541,141
Provision for refund liability
3,891,598
-
Provision for credit losses on other receivables
377,587
-
Deferred tax expenses (benefits)
428,999
(93,304)
Amortization of debt discount
-
495,000
Interest income
(64,000)
(63,996)
Stock-based compensation expense
1,570,419
468,489
Changes in operating assets and liabilities:
Accounts receivable
907,049
586,685
Other receivables
(3,345,149)
1,180,848
Prepaid expenses and other assets
(1,948,184)
(514,242)
Operating lease right of use assets and liabilities, net
(551)
1,889
Accounts payable and accrued expenses
2,358,113
(851,963)
Income taxes payable
(205,253)
(246,693)
Other current liabilities
(3,000,000)
-
Net cash provided by operating activities
3,133,813
2,176,209
CASH FLOWS FROM INVESTING ACTIVITIES:
Development of software
(3,189,921)
(900,755)
Interest received from loans receivable
64,000
64,000
Net cash used in investing activities
(3,125,921)
(836,755)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock in connection with
initial public offering, net of underwriting discounts and
commissions
-
8,214,000
Proceeds from stock option exercises
23,430
-
Payments of deferred offering costs
(210,816)
(1,975,556)
Repayments of notes payable
-
(2,145,000)
Net cash provided by (used in) financing activities
(187,386)
4,093,444
Increase (decrease) in cash and cash equivalents
(179,494)
5,432,898
Cash and cash equivalents, beginning of year
7,849,248
2,416,350
Cash and cash equivalents, end of year
7,669,754
7,849,248
Supplemental disclosures of cash flow information:
Cash paid for interest
$-
$-
Cash paid for income taxes
$830,726
$558,521
Summary of noncash investing and financing activities:
Accrued deferred offering costs included in accounts
payable and accrued expenses
$-
$39,839
Accrued development of software included in accounts
payable and accrued expenses
$38,363
$50,000
Reclassification of deferred offering costs to additional paid-
in capital upon initial public offering
$-
$2,277,164
Stock-based compensation capitalized for software
development
$290,726
$-
Health In Tech, Inc.
Reconciliation of GAAP (Net Income) to Non-GAAP Financial Measure (Adjusted EBITDA)
Three Months Ended
December 31,
Fiscal Year Ended
December 31,
2025
2024
2025
2024
Net income
(302,557)
(144,152)
1,278,842
670,477
Interest (income) expenses
(104,659)
(28,774)
(409,922)
372,115
Amortization expense
410,630
135,983
900,577
541,141
Income tax expense
(141,184)
33,404
395,330
218,523
Stock-based compensation expense
76,733
468,489
1,570,419
468,489
Provision for credit losses on other
receivables
377,587
-
377,587
-
Total net adjustments
619,107
609,102
2,833,991
1,600,268
Adjusted EBITDA
316,550
464,950
4,112,833
2,270,745
Investor Contact:
Health In Tech Investor Relations
[email protected]
The Equity Group
Kalle Ahl, CFA
T: (303) 953-9878
[email protected]
Devin Sullivan, Managing Director
[email protected]
SOURCE Health In Tech Inc.